Click to view your profile
Click to search for condition or expert
Click to open main menu
Non-Hodgkin Lymphoma Latest Advances
Find the Latest Research About Non-Hodgkin Lymphoma
Save
Bookmark
Share
Share
Overview
Find a Doctor
Latest Advances
Clinical Trials
Treatments
Customize your search results with filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 01/20/2023
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1207 publications
See more filters
A multicenter, phase II study of full-dose THP-COP therapy for elderly patients with newly diagnosed, advanced-stage, aggressive non-Hodgkin lymphoma.
Condition:
Elderly Patients with Advanced-Stage, Aggressive Non-Hodgkin Lymphoma (NHL)
Journal:
Journal of clinical and experimental hematopathology : JCEH
Treatment Used:
Pirarubicin and Modified CHOP Regimen (THP-COP)
Published:
December 27, 2022
VIEW PUBLICATION
Safety and Efficacy of Humanized Versus Murinized CD19 and CD22 CAR T-Cell Cocktail Therapy for Refractory/Relapsed B-Cell Lymphoma.
Condition:
Refractory/Relapsed (R/R) B-Cell Lymphoma
Journal:
Cells
Treatment Used:
Humanized Versus Murinized CD19 and CD22 CAR T-Cell Cocktail Therapy
Number of Patients:
126
Published:
December 23, 2022
VIEW PUBLICATION
Next-Generation Chimeric Antigen Receptor T-cells.
Condition:
B-Cell Non-Hodgkin Lymphoma (NHL) and Multiple Myeloma (MM)
Journal:
Hematology/oncology and stem cell therapy
Treatment Used:
CAR T-Cell Therapy
Published:
December 20, 2022
VIEW PUBLICATION
Chimeric Antigen Receptor T-cell Therapies in Lymphoma Patients with Central Nervous System Involvement.
Condition:
Central Nervous System (CNS) Lymphoma
Journal:
Hematology/oncology and stem cell therapy
Treatment Used:
CAR T-Cell Therapy
Number of Patients:
58
Published:
December 20, 2022
VIEW PUBLICATION
Rapid response in relapsed follicular lymphoma with massive chylous ascites to anti-CD19 CAR T therapy using Piggy Bac: A case report.
Condition:
Relapsed Follicular Lymphoma with Massive Chylous Ascites
Journal:
Frontiers in immunology
Treatment Used:
Anti-CD19 CAR T-Cell Therapy
Number of Patients:
1
Published:
December 19, 2022
VIEW PUBLICATION
Burkitt lymphoma.
Condition:
Burkitt Lymphoma (BL)
Journal:
Nature reviews. Disease primers
Treatment Used:
Chemotherapy
Published:
December 15, 2022
VIEW PUBLICATION
A retrospective study of 18 children with subcutaneous panniculitis-like T-cell lymphoma: multidrug combination chemotherapy or immunomodulatory therapy?
Condition:
Children with Subcutaneous Panniculitis T-Cell Lymphoma (SPTCL)
Journal:
Orphanet journal of rare diseases
Treatment Used:
Multidrug Combination Chemotherapy vs. Immunomodulatory Therapy
Number of Patients:
18
Published:
December 12, 2022
VIEW PUBLICATION
Glofitamab for Relapsed or Refractory Diffuse Large B-Cell Lymphoma.
Condition:
Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
Journal:
The New England journal of medicine
Treatment Used:
Glofitamab
Number of Patients:
155
Published:
December 12, 2022
VIEW PUBLICATION
Zanubrutinib plus salvage chemotherapy for relapsed or refractory diffuse large B-cell lymphoma.
Condition:
Diffuse Large B-Cell Lymphoma (DLBCL)
Journal:
Frontiers in immunology
Treatment Used:
Zanubrutinib Plus Salvage Chemotherapy
Number of Patients:
27
Published:
December 12, 2022
VIEW PUBLICATION
Efficacy Analysis of Bendamustine-Based Combination Regimen in Treatment of Patients with Relapsed/Refractory Non-Hodgkin Lymphoma.
Condition:
Relapsed/Refractory Non-Hodgkin Lymphoma
Journal:
Zhongguo shi yan xue ye xue za zhi
Treatment Used:
Bendamustine-Based Combination Regimen
Number of Patients:
18
Published:
December 08, 2022
VIEW PUBLICATION
High-dose extended-field radiotherapy plus chemotherapy improved survival in extranodal NK/T-cell lymphoma in a real-life setting: results from the multicenter T-Cell Brazil Project.
Condition:
Extranodal NK/T-Cell Lymphoma (ENKTL)
Journal:
Scientific reports
Treatment Used:
High-Dose Extended-Field Radiotherapy Plus Chemotherapy
Number of Patients:
98
Published:
November 29, 2022
VIEW PUBLICATION
Targeting the CD47-SIRPα Axis: Present Therapies and the Future for Cutaneous T-cell Lymphoma.
Condition:
Cutaneous T-cell Lymphoma
Journal:
Cells
Treatment Used:
Targeted anti-CD47 therapies
Published:
November 26, 2022
VIEW PUBLICATION
Showing 1-12 of 1,207
Next
Last Updated: 01/20/2023